GTS Securities’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,013
Closed -$214K 1403
2026
Q1
$214K Sell
1,013
-2,549
-72% -$549K 0.01% 1322
2025
Q4
$732K Buy
3,562
+2,058
+137% +$387K 0.03% 583
2025
Q3
$236K Buy
+1,504
New +$232K 0.01% 1188
2025
Q2
Sell
-11,555
Closed -$1.59M 1264
2025
Q1
$1.59M Buy
+11,555
New +$1.47M 0.07% 227
2024
Q4
Sell
-5,769
Closed -$638K 1676
2024
Q3
$638K Buy
5,769
+3,627
+169% +$379K ﹤0.01% 2592
2024
Q2
$211K Buy
+2,142
New +$218K ﹤0.01% 3409
2024
Q1
Sell
-6,807
Closed -$734K 3893
2023
Q4
$686K Sell
6,807
-21,611
-76% -$2.14M ﹤0.01% 2515
2023
Q3
$2.47M Buy
28,418
+18,306
+181% +$1.65M ﹤0.01% 1373
2023
Q2
$956K Buy
+10,112
New +$854K 0.03% 449

Other funds holding CAH

GTS Securities's CAH Position: Q2 2026 in Review

GTS Securities sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 1,013 shares — an estimated $214K sold.

GTS Securities first reported a position in CAH in Q2 2023 and held it in 9 quarters. The position peaked at $2.47M in Q3 2023. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • GTS Securities reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 1,013 Cardinal Health shares in Q2 2026, an estimated $214K.
  • GTS Securities first reported a position in Cardinal Health in Q2 2023 and held it in 9 quarters.
  • GTS Securities's Cardinal Health position peaked at $2.47M in Q3 2023.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.